Filter Recent Articles Filter Articles Clear filter 2023 2021 Publication Year 2025 2024 (-) 2023 2022 (-) 2021 2020 2019 2018 2017 2016 2015 2014 Media Releases 27 June, 2023 4min read ADAMA 2022 ESG Report Highlights Significant Progress in Portfolio and Operational Sustainability Media Releases 21 June, 2023 2min read ADAMA Receives Registration for Sierra®, the First Off-Patent, Self-Produced Saflufenacil-Based Product in Australia Media Releases 24 April, 2023 ADAMA Reports First Quarter 2023 Results Media Releases 03 April, 2023 2min read ADAMA Announces Steve Hawkins as President and CEO Media Releases 20 March, 2023 ADAMA Reports Full Year and Fourth Quarter 2022 Results Media Releases 14 March, 2023 2min read ADAMA Acquiring the Remaining Stakes of its Bio Stimulants Business in Chile Media Releases 16 February, 2023 4min read ADAMA Announces Recent Management Changes Media Releases 13 February, 2023 4min read ADAMA Opens New Multi-Purpose Plant in Brazil, Becoming a Leading Global Producer of Prothioconazole Media Releases 30 January, 2023 6min read ADAMA Provides Net Income Estimate for Full Year 2022 Media Releases 22 November, 2021 4min read ADAMA’s State-of-the-Art China Manufacturing Facility in Jingzhou Commences Operations Pagination Page 1 Current page 2 Page 3 … Share Line Linkedin Email Whatsapp Twitter Facebook
Media Releases 27 June, 2023 4min read ADAMA 2022 ESG Report Highlights Significant Progress in Portfolio and Operational Sustainability
Media Releases 21 June, 2023 2min read ADAMA Receives Registration for Sierra®, the First Off-Patent, Self-Produced Saflufenacil-Based Product in Australia
Media Releases 14 March, 2023 2min read ADAMA Acquiring the Remaining Stakes of its Bio Stimulants Business in Chile
Media Releases 13 February, 2023 4min read ADAMA Opens New Multi-Purpose Plant in Brazil, Becoming a Leading Global Producer of Prothioconazole
Media Releases 22 November, 2021 4min read ADAMA’s State-of-the-Art China Manufacturing Facility in Jingzhou Commences Operations
